share_log

国药一致盘中异动 早盘跳水5.02%

The traditional Chinese medicine dived 5.02% in the morning with the same intraday movement.

智能写手 ·  Jul 8, 2019 10:55

10:55 morning trading on July 8, 2019Traditional Chinese medicine is the same.(000028) there was a change, and the share price fell sharply by 5.02%. As of press time, the stock was reported at 40.51 yuan per share, with a turnover of 9215 lots, a turnover rate of 0.30%, an amplitude of 5.65%, and a volume ratio of 2.48.

The most recent day of the stock (2019-07-05) margin data are: financing balance of 219.5421 million yuan, financing purchases of 2.2234 million yuan, margin margin of 26800 shares, margin sales of 500 shares.

In terms of agency rating, in the past six months, one brokerage has given suggestions to increase its holdings, and five brokerages have given buying suggestions.

The stock has not risen by the limit or fallen by the limit in the past year.

The pharmaceutical circulation industry, where Chinese drugs are located, fell by 3.27% as a whole, and among its related stocksSea king creatureRuikang medicine* ST SaintsThe decline was larger, down 5.9%, 5.2%, 4.2%, respectively, by 5.9%, 4.2%, and 4.2%, respectively.JiashitangRuikang Pharmaceutical is more active, with turnover rates of 2.5%, 1.5% and 1.5%, respectively. Haiwang Bio, traditional Chinese medicine is the same, * ST Tiansheng has obvious dose, and the volume ratio is 2.9, 2.5, 2.5 and 2.3, respectively.Ginseng forestThe amplitudes of Ruikang Medicine are 5.6%, respectively, 5.2% and 4.8% respectively.

Guoyao Unification Co., Ltd. is mainly engaged in pharmaceutical commerce and pharmaceutical industry. As of July 08, 2019, the number of shareholders (households) of the company was 17550, a decrease of 551 compared with the last statistical day. (end)

(the above content is completed by Money Call, a self-selected intelligent machine writer, and can only be used as a reference for users to look at the disk, not as a basis for buying. )

The translation is provided by third-party software.


The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
    Write a comment